Chikungunya virus nonstructural protein 2 inhibits type I/II interferon-stimulated JAK-STAT signaling.
Chikungunya virus (CHIKV) is an emerging human pathogen transmitted by mosquitoes. Like that of other alphaviruses, CHIKV replication causes general host shutoff, leading to severe cytopathicity in mammalian cells, and inhibits the ability of infected cells to respond to interferon (IFN). Recent research, however, suggests that alphaviruses may have additional mechanisms to circumvent the host's antiviral IFN response. Here we show that CHIKV replication is resistant to inhibition by interferon once RNA replication has been established and that CHIKV actively suppresses the antiviral IFN response by preventing IFN-induced gene expression. Both CHIKV infection and CHIKV replicon RNA replication efficiently blocked STAT1 phosphorylation and/or nuclear translocation in mammalian cells induced by either type I or type II IFN. Expression of individual CHIKV nonstructural proteins (nsPs) showed that nsP2 was a potent inhibitor of IFN-induced JAK-STAT signaling. In addition, mutations in CHIKV-nsP2 (P718S) and Sindbis virus (SINV)-nsP2 (P726S) that render alphavirus replicons noncytopathic significantly reduced JAK-STAT inhibition. This host shutoff-independent inhibition of IFN signaling by CHIKV is likely to have an important role in viral pathogenesis.
Fros
Jelke J
JJ
Laboratory of Virology, Wageningen University, Droevendaalsesteeg 1, 6708 PB Wageningen, Netherlands.
Liu
Wen Jun
WJ
Prow
Natalie A
NA
Geertsema
Corinne
C
Ligtenberg
Maarten
M
Vanlandingham
Dana L
DL
Schnettler
Esther
E
Vlak
Just M
JM
Suhrbier
Andreas
A
Khromykh
Alexander A
AA
Pijlman
Gorben P
GP
D019943:Amino Acid Substitution; D000818:Animals; D001483:Base Sequence; D002460:Cell Line; D002646:Chikungunya virus / Q000187:drug effects / Q000235:genetics / Q000472:pathogenicity* / Q000502:physiology*; D002522:Chlorocebus aethiops; D006224:Cricetinae; D004279:DNA, Viral / Q000235:genetics; D005814:Genes, Viral; D006801:Humans; D007370:Interferon Type I / Q000494:pharmacology; D007371:Interferon-gamma / Q000494:pharmacology; D053612:Janus Kinases / Q000037:antagonists & inhibitors; D050505:Mutant Proteins / Q000737:chemistry / Q000235:genetics / Q000502:physiology; D009154:Mutation; D011994:Recombinant Proteins; D012093:Replicon; D050791:STAT Transcription Factors / Q000037:antagonists & inhibitors; D015398:Signal Transduction / Q000187:drug effects; D012845:Sindbis Virus / Q000235:genetics; D014709:Vero Cells; D017361:Viral Nonstructural Proteins / Q000737:chemistry / Q000235:genetics / Q000502:physiology*; D014779:Virus Replication / Q000187:drug effects / Q000502:physiology
D004279:DNA, Viral; D007370:Interferon Type I; D050505:Mutant Proteins; D011994:Recombinant Proteins; D050791:STAT Transcription Factors; D017361:Viral Nonstructural Proteins; D007371:Interferon-gamma; D053612:Janus Kinases